Non-systemic vasculitic neuropathy

Current Opinion in Neurology

Volumn 17, Issue 5, 2004, Pages 587-598

  Collins, Michael P ^a   Periquet, M Isabel ^b  

^a MARSHFIELD CLINIC   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Neuropathy; Pathogenesis; Prognosis; Treatment; Vasculitis

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

CELL ACTIVITY; CELL INFILTRATION; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; ELECTRODIAGNOSIS; ELECTROMYOGRAM; HUMAN; LABORATORY DIAGNOSIS; LABORATORY TEST; MOLECULAR DYNAMICS; NECROTIZING ARTERITIS; NERVE INJURY; NEUROPATHY; NON SYSTEMIC VASCULITIC NEUROPATHY; PATHOGENESIS; PATHOPHYSIOLOGY; PHARMACEUTICAL CARE; PLASMAPHERESIS; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN SECRETION; REVIEW; SIDE EFFECT; TREATMENT OUTCOME; VASCULITIS;

ANTI-INFLAMMATORY AGENTS; COHORT STUDIES; DIAGNOSIS, DIFFERENTIAL; HUMANS; MOTOR NEURONS; PERIPHERAL NERVOUS SYSTEM DISEASES; POLYNEUROPATHIES; PREDNISONE; TREATMENT OUTCOME; VASCULITIS;

EID: 6944255311     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-200410000-00009     Document Type: Review

References (110)

1. Fauci AS. The vasculitis syndromes. In: Braunwald E, Fauci AS, Kasper DL, et al., editors. Harrison's principles of internal medicine. New York: McGraw-Hill; 2001. pp. 1956-1968.
2. Collins MP, Kissel JT. Neuropathies with systemic vasculitis. In: Dyck PJ, Thomas PK, editors. Peripheral neuropathy. Elsevier, 2004; (in press).
3. Hunder GG, Arend WP, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. Arthritis Rheum 1990; 33:1065-1067.
4. Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994; 37:187-192.
5. Burke AP, Virmani R. Localized vasculitis. Semin Diagn Pathol 2001; 18:59-66.
6. Quinet RJ, Zakem JM, McCain M. Localized versus systemic vasculitis: diagnosis and management. Curr Rheumatol Rep 2003; 5:93-99. A review article summarizing the many types of localized vasculitis, categorized according to organ involvement and histology, with an emphasis on treatment and prognosis.
7. Kelley RE. CNS vasculitis. Front Biosci 2004; 9:946-955.
8. Ropper AH, Ayata C, Adelman L. Vasculitis of the spinal cord. Arch Neurol 2003; 60:1791-1794.
9. Nakamura T, Tomoda K, Yamamura Y, et al. Polyarteritis nodosa limited to calf muscles: a case report and review of the literature. Clin Rheumatol 2003; 22:149-153.
10. Burke AP, Sobin LH, Virmani R. Localized vasculitis of the gastrointestinal tract. Am J Surg Pathol 1995; 19:338-349.
11. Plaut A. Asymptomatic focal arteritis of the appendix; 88 cases. Am J Pathol 1951; 27:247-263.
12. Francke ML, Mihaescu A, Chaubert P. Isolated necrotizing arteritis of the female genital tract: a clinicopathologic and immunohistochemical study of 11 cases. Int J Gynecol Pathol 1998; 17:193-200.
13. Shurbaji MS, Epstein JI. Testicular vasculitis: implications for systemic disease. Hum Pathol 1988; 19:186-189.
14. Trueb RM, Scheidegger EP, Pericin M, et al. Periarteritis nodosa presenting as a breast lesion: report of a case and review of the literature. Br J Dermatol 1999; 141:1117-1121.
15. Daoud MS, Hutton KP, Gibson LE. Cutaneous periarteritis nodosa: a clinicopathological study of 79 cases. Br J Dermatol 1997; 136:706-713.
16. Walton RC, Ashmore ED. Retinal vasculitis. Curr Opin Ophthalmol 2003; 14:413-419.
17. Medvedev G, Al Shamari AE, Copland MA, Magil AB. Isolated renal giant cell arteritis. Am J Kidney Dis 2002; 40:658-661.
18. Swalwell CI, Reddy SK, Rao VJ. Sudden death due to unsuspected coronary vasculitis. Am J Forensic Med Pathol 1991; 12:306-312.
19. Jennings CA, King TE Jr, Tuder R, et al. Diffuse alveolar hemorrhage with underlying isolated, pauciimmune pulmonary capillaritis. Am J Respir Crit Care Med 1997; 155:1101-1109.
20. Dyck PJ, Benstead TJ, Conn DL, et al. Nonsystemic vasculitic neuropathy. Brain 1987; 110:843-853.
21. Kernohan JW, Woltman HW. Periarteritis nodosa: a clinicopathological study with special reference to the nervous system. Arch Neurol Psychiatry 1938; 39:655-686.
22. Kissel JT, Slivka AP, Warmolts JR, Mendell JR. The clinical spectrum of necrotizing angiopathy of the peripheral nervous system. Ann Neurol 1985; 18:251-257.
23. Said G, Lacroix-Ciaudo C, Fujimura H, et al. The peripheral neuropathy of necrotizing arteritis: a clinicopathological study. Ann Neurol 1988; 23:461-465.
24. Davies L, Spies JM, Pollard JD, McLeod JG. Vasculitis confined to peripheral nerves. Brain 1996; 119:1441-1448.
25. Collins MP, Periquet MI, Mendell JR, et al. Nonsystemic vasculitic neuropathy: Insights from a clinical cohort. Neurology 2003; 61:623-630. An analysis of a cohort of 48 patients with NSVN, detailing the clinical features, pathological findings, treatment, and outcome. This is the only NSVN series in which treatment responses were analysed. A key finding was that combination therapy produced a better outcome than corticosteroid monotherapy.
26. Puechal X, Said G. Necrotizing vasculitis of the peripheral nervous system: nonsystemic or clinically undetectable? Arthritis Rheum 1999; 42:824-825.
27. Abgrall S, Mouthon L, Cohen P, et al. Localized neurological necrotizing vasculitides. Three cases with isolated mononeuritis multiplex. J Rheumatol 2001; 28:631-633.
28. Behari M, Garg R, Dinda AK, Ahuja GK. Peripheral neuropathy due to small vessel vasculitis. J Assoc Phys India 1995; 43:495-497.
29. Bosboom WM, Van den Berg LH, Mollee I, et al. Sural nerve T-cell receptor Vbeta gene utilization in chronic inflammatory demyelinating polyneuropathy and vasculitic neuropathy. Neurology 2001; 56:74-81.
30. Cantalejo MM, Villalba YA, Bernad PM, Martin ME. Polineuropatia y vasculitis de vaso pequeno con deteccion de p-ANCA identidad mieloperoxidasa. Rev Clin Esp 2000; 200:700-701.
31. de la Sayette V, Macro M, Diraison P, et al. Acute necrotizing vasculitis (polyarteritis nodosa?) confined to the nerve with spontaneous recovery. Br J Rheumatol 1995; 34:694-695.
32. Fung VS, Walker GL, Yiannikas C. Nonsystemic vasculitic neuropathy presenting as progressive paraplegia. Muscle Nerve 1997; 20:766-767.
33. Garces SM, Villanueva-Haba VE, Sevilla MT, et al. Neuropatia vasculitica no sistemica. Neurologia 2002; 17:616-620.
34. Hagiwara N, Sekijima Y, Hattori T, et al. Two patients with different types of vasculitic neuropathy - a comparison between cutaneous polyarteritis nodosa and nonsystemic vasculitic neuropathy [in Japanese]. Rinsho Shinkeigaku 2003; 43:102-108.
35. Khalili-Shirazi A, Gregson NA, Londei M, et al. The distribution of CD1 molecules in inflammatory neuropathy. J Neurol Sci 1998; 158:154-163.
36. Larrode P, Cajal S, Iniguez C, et al. Vasculitis aislada del sistema nervioso periferico (VASNP). Neurologia 1997; 12:197-199.
37. Leppert D, Hughes P, Huber S, et al. Matrix metalloproteinase upregulation in chronic inflammatory demyelinating polyneuropathy and nonsystemic vasculitic neuropathy. Neurology 1999; 53:62-70.
38. Marcaud V, Gauthier C, Maisonobe T, et al. Vascularite restreinte au systeme nerveux peripherique: presentation clinique atypique. Rev Med Interne 2002; 23:558-562.
39. Molyneux PD, Barker R, Thomas PK, et al. Non-systemic vasculitic neuropathy presenting with a painful polyradiculopathy: a case report. J Neurol 2000; 247:645-646.
40. Murthy JM, Sundaram C, Meena AK. Nonsystemic vasculitic neuropathy. J Assoc Phys India 1998; 46:204-206.
41. Nicolai A, Bonetti B, Lazzarino LG, et al. Peripheral nerve vasculitis: a clinicopathological study. Clin Neuropathol 1995; 14:137-141.
42. Oguni E, Watanabe S, Nagata H, et al. A case of nonsystemic vasculitic neuropathy with anti-neutrophil cytoplasm antibody (ANCA) [in Japanese]. Rinsho Shinkeigaku 1994; 34:470-473.
43. Ohkoshi N, Mizusawa H, Oguni E, Shoji S. Sural nerve biopsy in vasculitic neuropathies: morphometric analysis of the caliber of involved vessels. J Med 1996; 27:153-170.
44. Panegyres PK, Blumbergs PC, Leong AS, Bourne AJ. Vasculitis of peripheral nerve and skeletal muscle: clinicopathological correlation and immunopathic mechanisms. J Neurol Sci 1990; 100:193-202.
45. Rosenbaum JT, Bell LA, Rosenbaum RB. Nonsystemic necrotizing vasculitis of the peripheral nervous system. Arthritis Rheum 1998; 41:1324-1325.
46. Sanada M, Terada M, Suzuki E, et al. MR angiography for the evaluation of non-systemic vasculitic neuropathy. Acta Radiol 2003; 44:316-318. A case report of a patient with NSVN detailing the first use of MRA in this condition. MRA-evidenced occlusions in the distal tibial and peroneal arteries later resolved with treatment.
47. Satoi H, Oka N, Kawasaki T, et al. Mechanisms of tissue injury in vasculitic neuropathies. Neurology 1998; 50:492-496.
48. Singhal BS, Khadilkar SV, Gursahani RD, Surya N. Vasculitic neuropathy: profile of twenty patients. J Assoc Phys India 1995; 43:459-461.
49. Tsunemi T, Yokota T, Kikyo H, et al. Nonsystemic vasculitic neuropathy presenting with truncal segmental sensory disturbance and hyperhidrosis. Muscle Nerve 1999; 22:646-647.
50. Engelhardt A, Lorler H, Neundorfer B. Immunohistochemical findings in vasculitic neuropathies. Acta Neurol Scand 1993; 87:318-321.
51. Dyck PJ, Engelsfad J, Norell J, Dyck PJ. Microvasculitis in non-diabetic lumbosacral radiculoplexus neuropathy (LSRPN): similarity to the diabetic variety (DLSRPN). J Neuropathol Exp Neurol 2000; 59:525-538.
52. Midroni G, Bilbao JM. Biopsy diagnosis of peripheral neuropathy. Boston: Butterworth-Heinemann; 1995. pp. 241-262.
53. Lie JT. Systemic and isolated vasculitis. A rational approach to classification and pathologic diagnosis. Pathol Annu 1989; 24:25-114.
54. Dyck PJ, Norell JE, Dyck PJ. Microvasculitis and ischemia in diabetic lumbosacral radiculoplexus neuropathy. Neurology 1999; 53:2113-2121.
55. Collins MP, Mendell JR, Periquet MI, et al. Superficial peroneal nerve/peroneus brevis muscle biopsy in vasculitic neuropathy. Neurology 2000; 55:636-643.
56. Collins MP, Mendell JR, Periquet MI, et al. Immunostaining in vasculitic neuropathy: sensitivity and specificity of findings. Ann Neurol 1997; 42:415.
57. Gurer G, Erdem S, Kocaefe C, et al. Expression of matrix metalloproteinases in vasculitic neuropathy. Rheumatol Int (online). Available on www.springerlink.com. Accessed 4 November 2003. An immunohistochemical and polymerase chain reaction analysis of MMP-2 and MMP-9 expression in sural nerve biopsies of 12 patients with vasculitic neuropathy (eight NSVN) and eight with non-inflammatory neuropathies, revealing a significantly increased expression of MMP-9 in perivascular inflammatory infiltrates in vasculitic neuropathy patients, colocalized with CD8 T cells.
58. Gherardi RK, Mhiri C, Baudrimont M, et al. Iron pigment deposits, small vessel vasculitis, and erythrophagocytosis in the muscle of human immunodeficiency virus-infected patients. Hum Pathol 1991; 22:1187-1194.
59. Chia L, Fernandez A, Lacroix C, et al. Contribution of nerve biopsy findings to the diagnosis of disabling neuropathy in the elderly. A retrospective review of 100 consecutive patients. Brain 1996; 119:1091-1098.
60. Hattori N, Mori K, Misu K, et al. Mortality and morbidity in peripheral neuropathy associated Churg-Strauss syndrome and microscopic polyangiitis. J Rheumatol 2002; 29:1408-1414.
61. McManis PG, Low PA, Lagerlund TD. Microenvironment of nerve: blood flow and ischemia. In: Dyck PJ, Thomas PK, Griffin JW, et al., editors. Peripheral neuropathy. Philadelphia: W.B. Saunders Co.; 1993. pp. 1424-1436.
62. Oh SJ. Paraneoplastic vasculitis of the peripheral nervous system. Neurol Clin 1997; 15:849-863.
63. Dyck PJ, Windebank AJ. Diabetic and nondiabetic lumbosacral radiculoplexus neuropathies: new insights into pathophysiology and treatment. Muscle Nerve 2002; 25:477-491.
64. Llewelyn JG, Thomas PK, King RH. Epineurial microvasculitis in proximal diabetic neuropathy. J Neurol 1998; 245:159-165.
65. Dyck PJ, Norell JE, Dyck PJ. Non-diabetic lumbosacral radiculoplexus neuropathy: natural history, outcome and comparison with the diabetic variety. Brain 2001; 124:1197-1207.
66. Bradley WG, Chad D, Verghese JP, et al. Painful lumbosacral plexopathy with elevated erythrocyte sedimentation rate: a treatable inflammatory syndrome. Ann Neurol 1984; 15:457-464.
67. Verma A, Bradley WG. High-dose intravenous immunoglobulin therapy in chronic progressive lumbosacral plexopathy. Neurology 1994; 44:248-250.
68. Triggs WJ, Young MS, Eskin T, Valenstein E. Treatment of idiopathic lumbosacral plexopathy with intravenous immunoglobulin. Muscle Nerve 1997; 20:244-246.
69. Rosenberg GA. Matrix metalloproteinases in neuroinflammation. Glia 2002; 39:279-291.
70. Briemberg HR, Levin K, Amato AA. Multifocal conduction block in peripheral nerve vasculitis. J Clin Neuromusc Dis 2002; 3:153-158.
71. Magistris MR, Kohler A, Estade M. Conduction block in vasculitic neuropathy. Eur Neurol 1994; 34:283-285.
72. Bouche P, Leger JM, Travers MA, et al. Peripheral neuropathy in systemic vasculitis: clinical and electrophysiologic study of 22 patients. Neurology 1986; 36:1598-1602.
73. Vilppula A. Muscular disorders in some collagen diseases. A clinical, electromyographic and biopsy study. Acta Med Scand Suppl 1972; 540:1-47.
74. Wees SJ, Sunwoo IN, Oh SJ. Sural nerve biopsy in systemic necrotizing vasculitis. Am J Med 1981; 71:525-532.
75. Low PA, Lagerlund TD, McManis PG. Nerve blood flow and oxygen delivery in normal, diabetic, and ischemic neuropathy. Int Rev Neurobiol 1989; 31:355-438.
76. Midroni G, Bilbao JM. Biopsy diagnosis of peripheral neuropathy. Boston: Butterworth-Heinemann; 1995. pp. 105-117.
77. Hawke SH, Davies L, Pamphlett R, et al. Vasculitic neuropathy. A clinical and pathological study. Brain 1991; 114:2175-2190.
78. Prayson RA, Sedlock DJ. Clinicopathologic study of 43 patients with sural nerve vasculitis. Hum Pathol 2003; 34:484-490. A pathological study of sural nerve biopsy findings in 43 patients with vasculitic neuropathy. Patients were not subdivided by the type of vasculitis.
79. Fujimura H, Lacroix C, Said G. Vulnerability of nerve fibres to ischaemia. A quantitative light and electron microscope study. Brain 1991; 114:1929-1942.
80. Vital A, Vital C. Polyarteritis nodosa and peripheral neuropathy. Ultrastructural study of 13 cases. Acta Neuropathol 1985; 67:136-141.
81. Bosboom WM, van den Berg LH, De Boer L, et al. The diagnostic value of sural nerve T cells in chronic inflammatory demyelinating polyneuropathy. Neurology 1999; 53:837-845.
82. Kissel JT, Riethman JL, Omerza J, et al. Peripheral nerve vasculitis: immune characterization of the vascular lesions. Ann Neurol 1989; 25:291-297.
83. Lindenlaub T, Sommer C. Cytokines in sural nerve biopsies from inflammatory and non-inflammatory neuropathies. Acta Neuropathol 2003; 105:593-602. An interesting immunohistochemical analysis of cytokine expression in sural nerve biopsies of 17 patients with vasculitic neuropathy (14 NSVN), 14 with chronic inflammatory demyelinating polyneuropathy, 10 with non-inflammatory neuropathies, and three normal controls. Patients with vasculitic neuropathy exhibited increased TNF-α, IL-1β and IL-6 immunoreactivity in epineurial T cells and endothelial macrophages.
84. Van RI, van den Berg LH, Bosboom WM, et al. Expression of accessory molecules for T-cell activation in peripheral nerve of patients with CIDP and vasculitic neuropathy. Brain 2000; 123:2020-2029.
85. Russell JH, Ley TJ. Lymphocyte-mediated cytotoxicity. Annu Rev Immunol 2002; 20:323-370.
86. Shresta S, Pham CT, Thomas DA, et al. How do cytotoxic lymphocytes kill their targets? Curr Opin Immunol 1998; 10:581-587.
87. Heuss D, Probst-Cousin S, Kayser C, Neundorfer B. Cell death in vasculitic neuropathy. Muscle Nerve 2000; 23:999-1004.
88. Lieberman J. The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal. Nat Rev Immunol 2003; 3:361-370.
89. Clayberger C, Krensky AM. Granulysin. Curr Opin Immunol 2003; 15:560-565.
90. Wajant H. The Fas signaling pathway: more than a paradigm. Science 2002; 296:1635-1636.
91. Deprez M, Lubke U, Verlaet M, et al. Detection of cytokines in human sural nerve biopsies: an immunohistochemical and molecular study. Acta Neuropathol 2001; 101:393-404.
92. Umansky V, Schirrmacher V. Nitric oxide-induced apoptosis in tumor cells. Adv Cancer Res 2001; 82:107-131.
93. Hartung HP, Kieseier BC. The role of matrix metalloproteinases in autoimmune damage to the central and peripheral nervous system. J Neuroimmunol 2000; 107:140-147.
94. Leppert D, Waubant E, Galardy R, et al. T cell gelatinases mediate basement membrane transmigration in vitro. J Immunol 1995; 154:4379-4389.
95. Engel AG, Biesecker G. Complement activation in muscle fiber necrosis: demonstration of the membrane attack complex of complement in necrotic fibers. Ann Neurol 1982; 12:289-296.
96. Jayne D. Current attitudes to the therapy of vasculitis. Kidney Blood Press Res 2003; 26:231-239.
97. Jayne D, Rasmussen N, Andrassy K, et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 2003; 349:36-44. One of relatively few randomized controlled treatment trials in any form of vasculitis. This study randomly assigned 144 patients in remission from ANCA-associated WG or MPA to 18 months of azathioprine or continued cyclophosphamide. There was no significant difference between the two groups in relapse rate and the incidence of severe adverse effects.
98. Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992; 116:488-498.
99. Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983; 98:76-85.
100. Gayraud M, Guillevin L, Le Toumelin P, et al. Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients. Arthritis Rheum 2001; 44:666-675.
101. Collins MP, Kissel JT. Vasculitis of the peripheral nervous system. In: Noseworthy JH, editor. Neurological therapeutics: principles and practice. London: Martin Dunitz; 2003. pp. 2078-2110.
102. Said G. Vasculitic neuropathy. Baillieres Clin Neurol 1995; 4:489-503.
103. Griffin JW. Vasculitic neuropathies. Rheum Dis Clin North Am 2001; 27:751-760.
104. Heuss D, Schlotter-Weigel B, Sommer C. Klinik, Diagnostik und Therapie der vaskulitischen Neuropathie. Bundeseinheitliche Konsensuspapiere der Muskelzentren im Auftrag der Deutschen Gesellschaft fur Muskelkranke. Fortschr Neurol Psychiatr 2003; 71:172-186.
105. Burns TM, Dyck PJB. Treatment of vasculitic neuropathy. In: Johnson RT, Griffin JW, McArthur JC, editors. Current therapy in neurologic disease. St Louis: Mosby; 2002. pp. 390-394.
106. Hattori N, Ichimura M, Nagamatsu M, et al. Clinicopathological features of Churg-Strauss syndrome-associated neuropathy. Brain 1999; 122:427-439.
107. Bligny D, Mahr A, Toumelin PL, et al. Predicting mortality in systemic Wegener's granulomatosis: a survival analysis based on 93 patients. Arthritis Rheum 2004; 51:83-91.
108. Aasarod K, Bostad L, Hammerstrom J, et al. Renal histopathology and clinical course in 94 patients with Wegener's granulomatosis. Nephrol Dial Transplant 2001; 16:953-960.
109. Reinhold-Keller E, Beuge N, Latza U, et al. An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients. Arthritis Rheum 2000; 43:1021-1032.
110. Moore PM, Fauci AS. Neurologic manifestations of systemic vasculitis. A retrospective and prospective study of the clinicopathologic features and responses to therapy in 25 patients. Am J Med 1981; 71:517-524.